Stockscreener 앱 받기
219.35
0.09%
-0.20
전일 마감가:
$219.55
열려 있는:
$219.45
하루 거래량:
1.31M
Relative Volume:
1.02
시가총액:
$6.90B
수익:
$302.00K
순이익/손실:
$-117.10M
주가수익비율:
-19.71
EPS:
-11.13
순현금흐름:
$-129.13M
1주 성능:
+0.75%
1개월 성능:
+112.51%
6개월 성능:
+735.62%
1년 성능:
+1,157%
1일 변동 폭
$218.86
$219.90
1주일 범위
$217.41
$220.41
52주 변동 폭
$15.22
$220.41
Cidara Therapeutics Inc Stock (CDTX) Company Profile
명칭
Cidara Therapeutics Inc
전화
858-752-6170
주소
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
CDTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
219.35 | 6.90B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-17 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-16 | 개시 | Morgan Stanley | Overweight |
| 2025-10-10 | 개시 | JP Morgan | Overweight |
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-03-12 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-01-27 | 재개 | Cantor Fitzgerald | Overweight |
| 2024-12-13 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-08 | 개시 | Guggenheim | Buy |
| 2024-08-14 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | 재개 | H.C. Wainwright | Buy |
| 2021-09-22 | 업그레이드 | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | 개시 | Aegis Capital | Buy |
| 2019-09-04 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2018-07-26 | 개시 | Citigroup | Buy |
| 2017-04-21 | 개시 | Raymond James | Strong Buy |
| 2017-04-17 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-12 | 개시 | Ladenburg Thalmann | Buy |
| 2017-04-11 | 재개 | Wedbush | Outperform |
| 2017-02-22 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-22 | 업그레이드 | WBB Securities | Sell → Hold |
| 2016-12-21 | 재개 | Leerink Partners | Outperform |
| 2016-12-19 | 개시 | H.C. Wainwright | Buy |
| 2016-09-23 | 다운그레이드 | WBB Securities | Hold → Sell |
| 2015-10-09 | 업그레이드 | WBB Securities | Sell → Hold |
| 2015-05-11 | 개시 | Jefferies | Buy |
| 2015-05-11 | 개시 | Leerink Partners | Outperform |
| 2015-05-11 | 개시 | Needham | Buy |
| 2015-05-11 | 개시 | Wedbush | Outperform |
| 2015-04-23 | 개시 | WBB Securities | Sell |
모두보기
Cidara Therapeutics Inc 주식(CDTX)의 최신 뉴스
Top Biotech Stocks To Watch TodayNovember 21st - MarketBeat
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Cheboygan Daily Tribune
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Promising Biotech Stocks To ConsiderNovember 18th - MarketBeat
Promising Mid Cap Stocks To ConsiderNovember 17th - MarketBeat
(CDTX) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Top Biotech Stocks To ConsiderNovember 20th - MarketBeat
Jefferies 25: Merck’s Cidara Buyout Could Help Meet Needs Of Increasingly Vaccine-Hesitant US - Citeline News & Insights
Merck Invests $9.2B in Cidara to Boost Breakthrough Flu Drug - BUCKSCO.Today
Can Cidara Therapeutics Inc. stock surprise with earnings upside2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Will Cidara Therapeutics Inc. (20D0) stock hit Wall Street targetsWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Will Cidara Therapeutics Inc. stock deliver long term returnsWeekly Gains Report & Smart Money Movement Tracker - newser.com
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer - AOL.com
Why Cidara Therapeutics Inc. stock could benefit from AI revolution2025 Winners & Losers & Verified Technical Signals - newser.com
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs? - Finviz
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. - Yahoo Finance
Merck deal shows potential of strain-agnostic flu protection - The Pharma Letter
Should you wait for a breakout in Cidara Therapeutics Inc.Market Risk Analysis & Short-Term High Return Ideas - newser.com
What to do if you’re stuck in Cidara Therapeutics Inc.Trend Reversal & Reliable Entry Point Alerts - newser.com
Will Cidara Therapeutics Inc. stock outperform international peersChart Signals & AI Optimized Trading Strategy Guides - newser.com
Is Cidara Therapeutics Inc. stock poised for growthEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Best Mid Cap Stocks To Add to Your WatchlistNovember 14th - MarketBeat
Using data models to predict Cidara Therapeutics Inc. stock movementMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Merck's Cidara Buyout Is An Opportunistic Win For Both PartiesHere's Why (NASDAQ:CDTX) - Seeking Alpha
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cidara ... - Black Hills Pioneer
Live market analysis of Cidara Therapeutics Inc.July 2025 Final Week & Risk Managed Investment Signals - newser.com
Cidara Therapeutics Inc (CDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):